OAC
ITCI

OMERS Administration Corp’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

OMERS Administration Corp’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,500
Closed -$308K – 1119
2024
Q2 		$308K Buy
+4,500
New +$312K ﹤0.01% 783
2017
Q4 		– Sell
-14,400
Closed -$227K – 478
2017
Q3 		$227K Buy
+14,400
New +$211K ﹤0.01% 398

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

OMERS Administration Corp's ITCI Position: Q3 2024 in Review

OMERS Administration Corp sold out of Intra-Cellular Therapies Inc. (ITCI) in Q3 2024, closing a stake of 4,500 shares — an estimated $308K sold.

OMERS Administration Corp first reported a position in ITCI in Q3 2017 and held it in 2 quarters. The position peaked at $308K in Q2 2024. 354 funds tracked by Wall St. Rank hold ITCI as of Q3 2024.

  • OMERS Administration Corp reported no remaining Intra-Cellular Therapies Inc. position as of Q3 2024 after selling out during the quarter.
  • OMERS Administration Corp sold 4,500 Intra-Cellular Therapies Inc. shares in Q3 2024, an estimated $308K.
  • OMERS Administration Corp first reported a position in Intra-Cellular Therapies Inc. in Q3 2017 and held it in 2 quarters.
  • OMERS Administration Corp's Intra-Cellular Therapies Inc. position peaked at $308K in Q2 2024.
  • 354 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q3 2024.

Based on OMERS Administration Corp's 13F filing for Q3 2024, filed 13 Nov 2024.